Literature DB >> 15941834

Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.

P Härle1, R H Straub, R Wiest, A Mayer, J Schölmerich, F Atzeni, M Carrabba, M Cutolo, P Sarzi-Puttini.   

Abstract

OBJECTIVE: To study in parallel the outflow of the sympathetic nervous system (SNS) and the hypothalamic-pituitary adrenal (HPA) axis tone in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
METHODS: 32 patients with SLE, 62 with RA, and 65 healthy subjects (HS) were included. To measure the tone of the HPA axis, plasma ACTH and serum cortisol were determined. Serum neuropeptide Y (NPY) was used to evaluate the sympathetic outflow.
RESULTS: Patients with SLE had increased NPY levels in comparison with HS, irrespective of prior prednisolone treatment (p<0.001). For patients with RA, only those with prednisolone treatment had increased NPY levels in comparison with HS (p = 0.016). Daily prednisolone dose correlated positively with serum NPY in RA (R(Rank) = 0.356, p = 0.039). In contrast, plasma ACTH levels were generally decreased significantly in comparison with HS in SLE with prednisolone, and in RA with/without prednisolone. Similarly, serum cortisol levels were also decreased in SLE with/without prednisolone, and in RA with prednisolone. The NPY/ACTH ratio was increased in SLE and RA, irrespective of prior prednisolone treatment. The NPY/cortisol ratio was increased in SLE with/without prednisolone, and in RA with prednisolone. Twelve weeks' anti-TNF antibody treatment with adalimumab did not decrease NPY levels in RA, irrespective of prednisolone treatment.
CONCLUSIONS: An increased outflow of the SNS was shown and a decreased tone of the HPA axis in patients with SLE and RA. Low levels of cortisol in relation to SNS neurotransmitters may be proinflammatory because cooperative anti-inflammatory coupling of the two endogenous response axes is missing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941834      PMCID: PMC1797997          DOI: 10.1136/ard.2005.038059

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  54 in total

1.  Renal and systemic plasma immunoreactive neuropeptide Y and calcitonin gene-related peptide responses to mental stress and adrenaline in humans.

Authors:  B Tidgren; E Theodorsson; P Hjemdahl
Journal:  Clin Physiol       Date:  1991-01

2.  Altered autonomic function in patients with arthritis or with chronic myofascial pain.

Authors:  Franklin Perry; Philip H Heller; Joe Kamiya; Jon D Levine
Journal:  Pain       Date:  1989-10       Impact factor: 6.961

3.  Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport.

Authors:  J M Lundberg; A Rudehill; A Sollevi; G Fried; G Wallin
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

4.  Participation of interleukin-1 and tumor necrosis factor in the responses of the sympathetic nervous system during lipopolysaccharide-induced fever.

Authors:  T Saigusa
Journal:  Pflugers Arch       Date:  1990-05       Impact factor: 3.657

5.  Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor.

Authors:  B Zietz; T Reber; M Oertel; T Glück; J Schölmerich; R H Straub
Journal:  J Rheumatol       Date:  2000-04       Impact factor: 4.666

6.  The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response.

Authors:  Y Dong; M Aronsson; J A Gustafsson; S Okret
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

7.  Modulation of glucocorticoid receptor expression in human articular chondrocytes by cAMP and prostaglandins.

Authors:  J A DiBattista; J Martel-Pelletier; J M Cloutier; J P Pelletier
Journal:  J Rheumatol Suppl       Date:  1991-02

8.  Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man.

Authors:  L Edvinsson; R Ekman; T Thulin
Journal:  Regul Pept       Date:  1991-02-26

9.  The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.

Authors:  M L Hetland; E Eldrup; P Bratholm; N J Christensen
Journal:  Scand J Clin Lab Invest       Date:  1991-05       Impact factor: 1.713

10.  Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation.

Authors:  M Cutolo; E Balleari; M Giusti; M Monachesi; S Accardo
Journal:  Arthritis Rheum       Date:  1988-10
View more
  32 in total

Review 1.  [Why are there analogous disease mechanisms in chronic inflammatory diseases?].

Authors:  Rainer H Straub; Hugo O Besedovsky; Adriana Del Rey
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

2.  Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity.

Authors:  Forough Sanaee; John D Clements; Alistair W G Waugh; Richard N Fedorak; Richard Lewanczuk; Fakhreddin Jamali
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

3.  Effects of 60-day bed rest with and without exercise on cellular and humoral immunological parameters.

Authors:  Paula Hoff; Daniel L Belavý; Dörte Huscher; Annemarie Lang; Martin Hahne; Anne-Kathrin Kuhlmey; Patrick Maschmeyer; Gabriele Armbrecht; Rudolf Fitzner; Frank H Perschel; Timo Gaber; Gerd-Rüdiger Burmester; Rainer H Straub; Dieter Felsenberg; Frank Buttgereit
Journal:  Cell Mol Immunol       Date:  2014-11-10       Impact factor: 11.530

4.  The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Alaa Quisi; Gökhan Alıcı
Journal:  J Clin Lab Anal       Date:  2018-06-26       Impact factor: 2.352

5.  Race differences in the relation of vitamins A, C, E, and β-carotene to metabolic and inflammatory biomarkers.

Authors:  Edward C Suarez; Nicole L Schramm-Sapyta
Journal:  Nutr Res       Date:  2013-10-14       Impact factor: 3.315

6.  R-R interval variation and sympathetic skin response in systemic lupus erythematosus.

Authors:  Aslan Tekatas; Süleyman Serdar Koca; Demet Deniz Tekatas; Feyza Aksu; Yüce Dogru; Omer Nuri Pamuk
Journal:  Clin Rheumatol       Date:  2013-09-22       Impact factor: 2.980

7.  A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation.

Authors:  Melissa A Rosenkranz; Richard J Davidson; Donal G Maccoon; John F Sheridan; Ned H Kalin; Antoine Lutz
Journal:  Brain Behav Immun       Date:  2012-10-22       Impact factor: 7.217

Review 8.  Enhanced pain perception in rheumatoid arthritis: novel considerations.

Authors:  Patrick B Wood
Journal:  Curr Pain Headache Rep       Date:  2009-12

9.  Impaired hypothalamo-pituitary-adrenal axis in patients with ankylosing spondylitis.

Authors:  L Kebapcilar; O Bilgir; A Alacacioglu; Y Yildiz; A Taylan; R Gunaydin; A Yuksel; B Karaca; I Sari
Journal:  J Endocrinol Invest       Date:  2009-07-20       Impact factor: 4.256

10.  Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.

Authors:  Suncica Buljevic; Dijana Detel; Lara Baticic Pucar; Radovan Mihelic; Tomislav Madarevic; Branko Sestan; Jadranka Varljen
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.